Kansas City Southern to Accept CN’s $33.6 Bil...

Up next

Instant Reaction: The Fed Decides

The Federal Reserve raised interest rates by a quarter percentage point and penciled in an additional hike later this year, steps aimed at containing inflation that will test Chairman Kevin Warsh’s relationship with President Donald Trump. “Today’s policy action will support a ti ... Show more

. 30min 54sec

How Couples Navigate Finance: Live from Future Proof

The people, companies and trends shaping the global economy. Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.On this special edition of the show, Carol Massar and Tim Stenovec speak with Doug and Heather Boneparth of Bone Fide Wealth. Authors of the book, 'Mo ... Show more

. 11min 17sec

Recommended Episodes

P&L: Training for Modern Jobs Is the Answer to Wage Stagnation

The Tape

Pimm Fox and Lisa Abramowicz talk to Chris Lu, deputy secretary for the Department of Labor, about the November jobs report. Then, Global Markets' Peter Kenny discusses why the infrastructure sector is overbought. Also, Algebris Investments' Alberto Gallo talks about the ECB and ... Show more

. 26min 4sec

Apple's Low-Cost iPhone Rollout At Risk From Virus

The Tape

John Butler, Senior Telecom Services & Equipment Analyst for Bloomberg Intelligence, on the "coronavirus nightmare" for Apple and global electronics. Scott Clemons, Chief Investment Strategist at Brown Brothers Harriman, discusses his current investment outlook. Clint Watts, Dist ... Show more

. 30min 35sec

Amazon’s Health Care Threat Just Became A Reality: Ovide, Nisen

The Tape

Bloomberg Opinion’s Max Nisen, health care columnist, and Shira Ovide, technology columnist, on Amazon buying Pillback.Chris Whalen, Chairman of Whalen Global Advisors, on bank stocks continued losing streak, and the privatization of Fannie and Freddie. Leland Miler, CEO of China ... Show more

. 30min 26sec

Biogen Was The Train Wreck Everyone Saw Coming: Nisen (Podcast)

The Tape

Max Nisen, Bloomberg Opinion health care columnist, on Biogen plunging after the company and its partner Eisai announced it was halting their Alzheimer drug trial. Gad Levanon, Chief Economist: North America at the Conference Board, on the February Leading Index and the Fed decis ... Show more

. 28min 5sec